AbCheck s.r.o.

AbCheck s.r.o. is a Czech Republic-based startup specializing in the discovery and optimization of human therapeutic antibodies. Established in 2009, the company boasts a versatile technology platform that caters to specific needs and desired Target Product Profiles. Leveraging cutting-edge technologies such as microfluidics and rabbit mass humanization, alongside state-of-the-art phage/yeast display libraries, AbCheck delivers high-quality leads for its clients.

With a slogan that reads "Meeting Your Needs in Cutting-edge Antibody Discovery and Development," AbCheck has demonstrated its capabilities through multiple successful partnerships across the U.S. and Europe. As a wholly-owned subsidiary of Ampersand Biomedicines, a Flagship Pioneering Company, AbCheck is poised for continued growth and innovation in the Biopharma, Biotechnology, Life Sciences, and Pharmaceutical industries.

At present, there is no publicly available information regarding the last investment received by AbCheck or the associated investors. However, the company's track record and strategic positioning within the industry indicate its potential for attracting significant investment interest in the future.